Financial Statements · Financial Reporting
PharmaSynth AS
Official identifier 11044101Record date 31 Dec 2022
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2022
- Period start
- 1 Jan 2022
- Submitted date
- 21 Jun 2023
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 833,351 |
| Balance sheet | Cash and cash equivalents | 540,736 |
| Balance sheet | Current assets | 635,684 |
| Balance sheet | Current liabilities | 82,591 |
| Balance sheet | Equity | 750,760 |
| Balance sheet | Share capital at nominal value | 60,908 |
| Balance sheet | Non-current assets | 197,667 |
| Balance sheet | Retained earnings (loss) from previous periods | 562,325 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -26,510 |
| Income statement scheme 1 | Labour costs | -222,785 |
| Income statement scheme 1 | Revenue | 475,618 |
| Income statement scheme 1 | Annual period profit / loss | 121,436 |
| Income statement scheme 1 | Operating profit (loss) | 113,814 |
| Income statement scheme 1 | Profit (loss) before income tax | 121,436 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 562,325 |
| Note: Labour costs | Employees | 7 |
| Note: Labour costs | Labour costs | 222,785 |
Linked company
Company: PharmaSynth AS